Scientific Articles

Search verified research on molecular hydrogen.

Match

Showing 81–89 of 89 articles

Literature ReviewAnimal StudyIn VitroHighlighted

BENEFICIAL EFFECTS OF HYDROGEN IN THE CNS AND A NEW BRAIN-STOMACH INTERACTION

MHID-45285932014European Journal of Neurodegenerative Diseases

Mami Noda, M. Ito, I. Ohsawa, K. Ohno

A new medical gas, molecular hydrogen (H2), has been reported to be effective for a variety of disorders and clinical trials have shown promising results. Though the precise mechanism is still unknown, it is obvious that H2 has multiple effects. The first prominent effect of H2 was as antioxidant or reactive oxygen species (ROS)-scavenger, though it blocks only hydroxyl radicals (•OH), which are t

Literature ReviewHighlighted

Hydrogen as a New Class of Radioprotective Agent

MHID-2487803PMID: 306788962013International Journal of Biological Sciences

Liren Qian, Jianliang Shen, Yunhai Chuai, Jianming Cai

It is well known that most of the ionizing radiation-induced damage is caused by hydroxyl radicals (·OH) follows radiolysis of H2O. Molecular hydrogen (H2) has antioxidant activities by selectively reducing ·OH and peroxynitrite(ONOO-). We firstly hypothesized and demonstrated the ra-dioprotective effect of H2 in vitro and in vivo, which was also repeated on different experimental animal models by

Literature Review

The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance

MHID-0878205PMID: 236800322013Medical Gas Research

Brandon J Dixon, Jiping Tang, John H Zhang

Studies on molecular hydrogen have evolved tremendously from its humble beginnings and have continued to change throughout the years. Hydrogen is extremely unique since it has the capability to act at the cellular level. Hydrogen is qualified to cross the blood brain barrier, to enter the mitochondria, and even has the ability to translocate to the nucleus under certain conditions. Once in these i

Literature Review

Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases

MHID-2828070PMID: 238595552013Current Pharmaceutical Design

Toru Ishibashi

Rheumatoid arthritis (RA) is a chronic inflammatory disease in which the progressive destruction of joint causes morbidity. It is also associated with an increased risk of atherosclerosis, which can result in cardiovascular disease and mortality. The therapeutic goal is to control the systemic inflammation to obtain not only the remission of symptoms, but also improve general state of health. Alth

Literature Review

Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases

MHID-8352354PMID: 216215882012Biochimica et Biophysica Acta

Shigeo Ohta

Background: Mitochondria are the major source of oxidative stress. Acute oxidative stress causes serious damage to tissues, and persistent oxidative stress is one of the causes of many common diseases, cancer and the aging process; however, there has been little success in developing an effective antioxidant with no side effect. We have reported that molecular hydrogen has potential as an effectiv

Literature Review

Molecular Hydrogen as an Emerging Therapeutic Medical Gas for Neurodegenerative and Other Diseases

MHID-5039793PMID: 227201172012Oxidative Medicine and Cellular Longevity

Kinji Ohno, Mikako Ito, Masatoshi Ichihara, Masafumi Ito

Effects of molecular hydrogen on various diseases have been documented for 63 disease models and human diseases in the past four and a half years. Most studies have been performed on rodents including two models of Parkinson’s disease and three models of Alzheimer’s disease. Prominent effects are observed especially in oxidative stress-mediated diseases including neonatal cerebral hypoxia; Parkinson

Literature ReviewAnimal StudyHighlighted

Therapeutic Effects of Hydrogen in Animal Models of Parkinson’s Disease

MHID-2487138PMID: 257255222011Parkinson’s Disease

Kyota Fujita, Yusaku Nakabeppu, Mami Noda

Since the first description of Parkinson’s disease (PD) nearly two centuries ago, a number of studies have revealed the clinical symp- toms, pathology, and therapeutic approaches to overcome this intractable neurodegenerative disease. 1-methy-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA) are neurotoxins which produce Parkinsonian pathology. From the animal studies using

Human StudyLiterature ReviewAnimal StudyIn VitroHighlighted

The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas Research

MHID-1756030PMID: 221460822011Medical Gas Research

Shigeo Ohta, Atsunori Nakao, Kinji Ohno

This report summarizes a brief description/history of the Hydrogen Research Meetings as well as key presentations/oral abstracts delivered in the most recent symposium. Additionally, we introduced 38 diseases and physiological states for which hydrogen exhibits beneficial effects.

Literature Review

Hydrogen as a Selective Antioxidant: a Review of Clinical and Experimental Studies

MHID-2963789PMID: 212269922010The Journal of International Medical Research

Y Hong, S Chen, J-M Zhang

Oxidative stress is implicated in the pathogenesis of many diseases; however, currently used antioxidants have a high toxicity that constrains administration to a narrow window of therapeutic dosage. There is a clear need for more effective and safer antioxidants. Diatomic hydrogen (H2) was proposed as a novel antioxidant that selectively reduces levels of toxic reactive-oxygen species. Recently,